Clinical Study Results Sanofi Pharma, including Sanofi Genzyme

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter M

Generic Name Trade Name Condition Study Code Study Name Access to study Access to results
MAYTANSINOID LOADED ANTI-CD19 MAB Not marketed Lymphoma EFC11603 MYRALL NCT01440179
MAYTANSINOID LOADED ANTI-CD19 MAB Not marketed Lymphoma TCD12333 NA EudraCT: 2011-002865-39
MET INHIBITOR Not marketed Lung Cancer ACT14205 NA EudraCT: 2014-005696-93
MET INHIBITOR Not marketed Cancer TCD13388 NA NCT01985191
MET INHIBITOR Not marketed Cancer TED12337 SARMETA NCT01657214
MET INHIBITOR Not marketed Cancer TED11449 SARMET NCT01391533
Modified-Release Recombinant Human Thyroid Stimulating Hormone Thyrogen Goiter MRTSH01505 NA EudraCT: 2005-004451-35

*These study results were previously posted on
**This link replaces the same summary that was previously posted